Meadville Tribune

Breaking News

Our Health

March 5, 2014

Lilly's diabetes drug rejected by FDA

NEW YORK — A diabetes pill developed by Eli Lilly and Boehringer Ingelheim was rejected by U.S. regulators because of previously disclosed manufacturing deficiencies at a German plant that hadn't been resolved.

The Food and Drug Administration inspected Boehringer's Ingelheim am Rhein facility in 2012 and warned the Ingelheim- based company of the faults in May 2013. No new clinical studies will be needed to approved the drug, called empagliflozin, the companies said Wednesday in a statement.

"The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured," the companies said. The FDA won't approved the drug until the problems are fixed.

About 24 million people in the United States have diabetes, a condition often driven by obesity where the body loses its ability to process sugar.

Empagliflozin is part of a class of drugs that includes Johnson & Johnson's Invokana and AstraZeneca's Forxiga. The drugs help the body get rid of sugar through the kidneys.

The Lilly-Boehringer drug is projected to sell $295 million for Lilly in 2019, according to analyst estimates compiled by Bloomberg.

The FDA re-inspection of Boehringer's plant is continuing, said Emily Baier, a spokeswoman for the company. "The inspection is reviewing aspects related to production, processes, quality assurance and other related areas," said in an email. It could take up to six months after the inspection for the FDA to decide whether the problems have been fixed.

The 2012 inspection found what the FDA called "significant violations of current manufacturing practice" at the plant. They included a failure to look into issues with the active ingredients of drug made there as well as contamination problems that also weren't investigated.

The warning letter last year didn't specifically mention empagliflozin, Philip Johnson, Lilly's vice president of investor relations, said on a Jan. 7 conference call.

"Empagliflozin was not specifically cited in that warning letter," Johnson said. "There was other commercial production that was specifically referenced. Boehringer Ingelheim has been working through this with the FDA."

1
Text Only
Our Health
  • Don't let a desk job negatively impact your health

    If you’re female, you might want to consider a more physically active career to avoid a variety of cancers.

    July 21, 2014

  • Study focuses on cancer in those who apply pesticides

    This year marks the end of the Agricultural Health Study, a 20-year study of the effects of pesticides on farm workers and their families. Although the study focused on Iowa and North Carolina, there are still some elements that are important for Pennsylvania farmers as well as anyone who handles chemical compounds.

    June 30, 2014

  • Learn to swim and keep drowning at bay

    When you and your family hit the pool or the beach this summer, you need to be aware of a phenomenon known as secondary drowning, or dry drowning.

    June 16, 2014

  • ‘Planting’ the seeds of a better diet this summer

    Summertime is a great time to make improvements to your diet and lifestyle. Despite the conflicting “advice” you may get about diet when reading the popular press (not to mention all of the “food rules”), adding more plants to your diet is always a good idea.

    June 9, 2014

  • Is the idea of drinkable sunscreen worth swallowing?

    Tired of greasy, sticky hands after applying sunscreen? Even the spray-on sunscreens leave you inhaling fumes that you shouldn’t breathe. Well, enter a new era of skincare products: drinkable sunscreen.

    June 3, 2014

  • Survivor stories: Beating cancer with faith and family love

    I recently talked with Rebecca Arbuckle of Meadville to discuss her journey with breast cancer and how she was able to beat it with faith, strength and the love of her family. Although our conversation was upbeat and filled with confidence, there were times that emotion broke through, as it should, for having faced such a battle and won. I am in awe of the people I have had the chance to interview and am honored to share their stories.

    May 27, 2014

  • Uncovering the simple fix to the 'super bug'

    The World Health Organization has identified a serious threat to human health around the globe. Known as a “superbug,” this antimicrobial resistant bacterial infection has been coined “AMR” (Antimicrobial Resistance).

    May 19, 2014

  • Get educated about high blood pressure and eating better

    May is High Blood Pressure Education Month, and one in three Americans have it. High blood pressure (hypertension) is a leading risk factor for stroke. Hypertension is often referred to as the “silent killer” since you may feel no apparent symptoms. Yet, high blood pressure will cause damage to the blood vessels, brain and heart over time.

    May 13, 2014

  • Researchers: colon cleansing health benefits a myth

    Researchers have found that while colon cleansing has been around since ancient times, the health benefits are basically a myth.

    May 5, 2014

  • Prescription for Medical Nutrition Therapy

    Nutrition is a vital part of being well, and an even more important part to getting well (or healing). It’s a critical part of prevention, yet if I surveyed physicians or lay people, and asked them “Does diet therapy work?” chances are at least 70 percent of them would say “No.”

    April 21, 2014